Share

February 05, 2013; 80 (6) Editorial

Warfarin treatment and thrombolysis

How to persuade procrastinators?

Raymond C.S. Seet, Judith U. Harrer
First published December 5, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31827b1b3b
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
337

Share

This article has corrections. Please see:

Article Information

vol. 80 no. 6 512-513
DOI: 
https://doi.org/10.1212/WNL.0b013e31827b1b3b
PubMed: 
23223540
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published December 5, 2012.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Raymond C.S. Seet, MD and
    2. Judith U. Harrer, MD
  1. Raymond C.S. Seet, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. Non-profit entity: Research grants from the National Medical Research Council and National Research Foundation, Singapore.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Judith U. Harrer, MD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. (1) Commercial: Novartis Pharma, Speaker Honoraria

    Editorial Boards:

    1. 1) Neurology, Editorial Board Member, since 1.1.10

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. Georg Thieme Publishing House, translator, since 25.05.09

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Medicine (R.C.S.S.), Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Neurology (J.U.H.), Caritas Medical Center Saarbrücken, Saarbrücken; and the Department of Neurology (J.U.H.), RWTH Aachen University Hospital, Aachen, Germany.
  1. Correspondence to Dr. Seet: raymond_seet{at}nus.edu.sg
View Full Text

Article usage

Article usage: December 2012 to March 2023

AbstractFullPdfSource
Dec 20120049Highwire
Jan 2013008Highwire
Feb 20130194159Highwire
Mar 201301824Highwire
Apr 2013079Highwire
May 20130611Highwire
Jun 20132448Highwire
Jul 20133333Highwire
Aug 20132624Highwire
Sep 20132822Highwire
Oct 20132745Highwire
Nov 20131436Highwire
Dec 20132544Highwire
Jan 2014811Highwire
Feb 2014800Highwire
Mar 20141200Highwire
Apr 20142120Highwire
May 20142031Highwire
Jun 20143130Highwire
Jul 20142821Highwire
Aug 20142203Highwire
Sep 20141100Highwire
Oct 20141301Highwire
Nov 20142011Highwire
Dec 20141910Highwire
Jan 20151900Highwire
Feb 2015800Highwire
Mar 20155322Highwire
Apr 20151300Highwire
May 20153211Highwire
Jun 20151502Highwire
Jul 20151523Highwire
Aug 20153131Highwire
Sep 20151000Highwire
Oct 20151821Highwire
Nov 20152400Highwire
Dec 20155300Highwire
Jan 20161000Highwire
Feb 20161600Highwire
Mar 20161100Highwire
Apr 2016730Highwire
May 2016410Highwire
Jun 2016631Highwire
Jul 20161300Highwire
Aug 20161320Highwire
Sep 20163900Highwire
Oct 20163300Highwire
Nov 20161500Highwire
Dec 20161401Highwire
Jan 20171002Highwire
Feb 2017611Highwire
Mar 20171201Highwire
Apr 20171100Highwire
May 20172300Highwire
Jun 20171300Highwire
Jul 2017803Highwire
Aug 2017800Highwire
Sep 2017500Highwire
Oct 2017700Highwire
Nov 2017500Highwire
Dec 2017700Highwire
Jan 2018600Highwire
Feb 2018610Highwire
Mar 2018312Highwire
Apr 2018200Highwire
May 2018800Highwire
Jun 2018800Highwire
Jul 2018800Highwire
Aug 20181120Highwire
Sep 2018910Highwire
Oct 2018700Highwire
Nov 2018800Highwire
Dec 2018900Highwire
Jan 2019500Highwire
Feb 2019900Highwire
Mar 2019400Highwire
Apr 2019300Highwire
May 20191000Highwire
Jun 2019500Highwire
Jul 20191100Highwire
Aug 20191110Highwire
Sep 2019900Highwire
Oct 20191832Highwire
Nov 2019700Highwire
Dec 2019501Highwire
Jan 2020900Highwire
Feb 2020900Highwire
Mar 2020722Highwire
Apr 2020900Highwire
May 2020900Highwire
Jun 2020900Highwire
Jul 20201011Highwire
Aug 2020900Highwire
Sep 2020900Highwire
Oct 20201100Highwire
Nov 2020910Highwire
Dec 20201501Highwire
Jan 20211100Highwire
Feb 2021800Highwire
Mar 20212700Highwire
Apr 20211100Highwire
May 20211311Highwire
Jun 2021411Highwire
Jul 20212700Highwire
Aug 2021900Highwire
Sep 20211200Highwire
Oct 2021900Highwire
Nov 20212500Highwire
Dec 20211310Highwire
Jan 20221800Highwire
Feb 20222800Highwire
Mar 20221300Highwire
Apr 20221700Highwire
May 20222600Highwire
Jun 20221411Highwire
Jul 20221601Highwire
Aug 2022622Highwire
Sep 20221600Highwire
Oct 20221122Highwire
Nov 20223800Highwire
Dec 20222400Highwire
Jan 20235200Highwire
Feb 20231711Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me

Recommended articles